Discontinued — last reported Q3 '24
Cialis® — Revenue
Eli Lilly Cialis® — Revenue increased by 4.3% to $91.50M in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 5.4%, from $86.80M to $91.50M. Over 2 years (FY 2021 to FY 2023), Cialis® — Revenue shows a downward trend with a -27.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests sustained brand loyalty or successful market defense against generics, while a decrease indicates expected erosion due to patent expiration and generic competition.
Detailed definition
This metric represents the total global net sales generated from the Cialis product line, a phosphodiesterase type 5 inh...
Peer comparison
Comparable to legacy product revenue streams at other large-cap pharmaceutical companies, often characterized by steady decline curves following loss of exclusivity.
lly_segment_cialis_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $281.00M | $130.90M | $179.80M | $217.70M | $147.00M | $115.70M | $106.90M | $100.30M | $115.60M | $86.80M | $78.70M | $139.30M | $87.70M | $91.50M |
| QoQ Change | — | -53.4% | +37.4% | +21.1% | -32.5% | -21.3% | -7.6% | -6.2% | +15.3% | -24.9% | -9.3% | +77.0% | -37.0% | +4.3% |
| YoY Change | — | — | — | — | -47.7% | -11.6% | -40.5% | -53.9% | -21.4% | -25.0% | -26.4% | +38.9% | -24.1% | +5.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's cialis® — revenue?
- Eli Lilly (LLY) reported cialis® — revenue of $91.50M in Q3 2024.
- How has Eli Lilly's cialis® — revenue changed year-over-year?
- Eli Lilly's cialis® — revenue increased by 5.4% year-over-year, from $86.80M to $91.50M.
- What is the long-term trend for Eli Lilly's cialis® — revenue?
- Over 2 years (2021 to 2023), Eli Lilly's cialis® — revenue has grown at a -27.1% compound annual growth rate (CAGR), from $718.50M to $381.40M.
- What does cialis® — revenue mean?
- The total revenue generated from the sale of the drug Cialis.